The Impact of an Enhanced Recovery Protocol in a High-Risk Population Undergoing Colon Cancer Surgery.


Journal

The American surgeon
ISSN: 1555-9823
Titre abrégé: Am Surg
Pays: United States
ID NLM: 0370522

Informations de publication

Date de publication:
Nov 2023
Historique:
medline: 6 12 2023
pubmed: 16 8 2022
entrez: 15 8 2022
Statut: ppublish

Résumé

Enhanced Recovery ERP protocols (ERP) have improved surgical outcomes in patients undergoing elective colon cancer (CC) surgery; however, efficacy in different populations may vary. We examined the impact of an ERP in a population with high rates of obesity and multiple comorbidities. We performed a retrospective analysis of factors associated with postoperative complications (PoC) and length of stay (LOS) following CC surgery from 2011 to 2019 in a 5-hospital healthcare system which serves a population with higher rates of obesity (body mass index ≥30kg/m A total of 408 elective CC surgery patients with complete oncologic surgical data were identified. Of these, 191 (46.81%) were under ERP. Factors independently associated with PoC included obesity (OR=1.66, P=.029), laparoscopic (OR=.52, P=.020), and hybrid (OR=.38, P=.012) versus open surgery and ASA (American Society of Anesthesiologists) class ≥3 (OR=1.98, P=.006). ERP did not impact PoC but was associated with a reduction in LOS (β=-1.02 days, 95%CI: -1.75 - -.30, P=.006). ERP had an impact on LOS in both the non-obese and obese groups (P<.001 and P=.034, respectively). PoC significantly increased LOS (β=6.67 days, 95%CI: 5.41-7.03, P<.001). Following elective CC surgery, obesity and medical comorbidities were associated with increased PoC and in turn, as expected, increased LOS. ERP was associated with a reduction in LOS in both obese and non-obese patients. In high-risk populations, application of ERP may be particularly important to optimize surgical outcomes following CC surgery.

Identifiants

pubmed: 35969481
doi: 10.1177/00031348221121540
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4485-4495

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Denise L Wong (DL)

Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.

Alexis Holland (A)

Atrium Health Carolinas Medical Center, Charlotte, NC, USA.

Mehmet Kocak (M)

Istanbul Medipol University, International School of Medicine, Istanbul, Turkey.

Mace Coday (M)

Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.

Caroline Brown (C)

Prisma Health/University of South Carolina, Greenville, SC, USA.

Justin J Monroe (JJ)

Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.

Nathan M Hinkle (NM)

Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.

Jeremiah L Deneve (JL)

Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.

Evan S Glazer (ES)

Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.

David Shibata (D)

Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH